RoC’s Revival: The Comeback of a Heritage Brand as a Private Equity Powerhouse

Key Takeaways

  • RoC tripled its global retail sales from $100 million to $300 million and reclaimed the No.1 position in U.S. eye cream.
  • The brand’s transformation was driven by operational focus and a skilled leadership team rather than cosmetic changes.
  • Strategic operational independence and a refined product portfolio contributed to increased profitability and international expansion.

Reviving RoC: A Case Study in Growth

In 2018, RoC was a modest yet profitable division of a major healthcare conglomerate and faced declining sales. However, by 2024, it had achieved remarkable growth, tripling its global retail sales to $300 million and securing a $500 million exit to new ownership. The resurgence was not about reinventing the brand but rather enhancing its core strengths through disciplined focus and strong leadership.

Founded in 1957 by pharmacist Jean-Charles Lissarrague, RoC earned its reputation on dermatological rigor, especially with its stabilized retinol products. However, under Johnson & Johnson, the brand received less attention compared to billion-dollar brands, resulting in declining sales and limited innovation. By late 2010s, RoC’s U.S. sales were in decline, prompting J&J to divest the brand.

In 2019, private equity firm Gryphon acquired RoC, recognizing several enduring strengths, including strong brand equity and profitable operations. The initial focus was on reestablishing effective leadership and governance. Fernando Acosta joined as CEO and began to build a team, which included experts from leading cosmetic and consumer companies.

One of the first significant moves was achieving operational independence—an 18-month process that involved separating from J&J. This transition laid the groundwork for a sustainable growth strategy. A pivotal strategy was the consolidation of product offerings; about half of the existing SKUs were eliminated to boost operational efficiency and retailer confidence, concentrating instead on core products anchored around clinical retinol.

Channel strategy also underwent a significant rethink. While brick-and-mortar retail remained vital, RoC gradually increased its presence in e-commerce, particularly through Amazon. By 2025, digital sales accounted for nearly one-third of total revenues, supporting overall growth.

The brand’s international expansion began after stabilizing the U.S. business, targeting key European markets. This careful sequencing has allowed RoC to maintain robust growth while capturing market share effectively.

From 2020 to 2024, RoC reported impressive performance metrics, including a compound annual growth rate in net sales of around 20% and EBITDA margins that more than doubled. The brand has recorded 21 consecutive quarters of market share gains.

RoC’s successful transformation serves as a lesson in the importance of disciplined focus and strong leadership in the beauty sector. The brand illustrates that heritage does not require reinvention, and that narrowing focus and strategic operational independence can yield significant growth. The combination of capital investment, strategic patience, and capable leadership has allowed RoC to decisively reclaim its position in a highly competitive market.

The content above is a summary. For more details, see the source article.

Leave a Comment

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Become a member

RELATED NEWS

Become a member

Scroll to Top